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Ultrasonography (US) is a valuable tool for confirming the diagnosis of carpal tunnel syndrome (CTS) as it enables
the detection of changes in the median nerve shape and rule out anatomic variants as well as space-occupying
lesions such as ganglion cysts or tenosynovitis. This work was carried out aiming at: 1. Ultrasonography assessment
of the median nerve and its neurovascular blood-flow in CTS patients before and after management. 2. Verify the
possibility of using baseline US parameters as a biomarker to predict likely outcomes and frame a treatment plan
for CTS patients.
233 CTS subjects diagnosed based on clinical and electrophysiological (NCS) testing were included in this work. US
measures at the tunnel inlet included: cross sectional area, flattening ratio and neural Power Doppler (PD) signals.
Patients who had severe NCS outcomes or neurological deficit were referred for open surgical decompression; the
remaining patients were given the choice of either conservative or surgical management. The main outcome
variable was improvement >70% in CTS symptoms. Assessments were carried out at baseline, 1-week, 1-month
and 6-months post treatment. Results revealed an inverse relation between the neural vasculature and CTS severity
defined by NCS (r = − 0.648). In CTS cases treated conservatively, the US measures started to improve within
1-week, whereas in the surgically treated cohort there was an initial phase of post-operative nerve measures
increase, before settling at 1-month time of follow-up. The risk of poor outcomes was significantly higher (RR 3.3)
in patients with high median nerve flattening ratio. This risk was most marked in the cohort with nerve flattening
associated with longer duration of illness (RR 4.3) and low PD signal (RR 4.1). The results revealed that in addition
to the diagnostic value of US in CTS, the detection of increased median nerve neuro-vasculature has a good
prognostic value as an indicator of early median nerve affection.
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Carpal tunnel syndrome (CTS), first reported by Phalen
(1966), is one of the most common peripheral mono-
neuropathies which occurs due to localized compression
of the median nerve (MN) in the CT. With the introduc-
tion of new technology including computers, mobile
phones and tablets, its prevalence increased significantly
and it has been reported to represent up to 90% of all* Correspondence: drelmiedany@rheumatology4u.com
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reproduction in any medium, provided the origentrapment neuropathies (El Miedany et al. 2004; Aroori
and Spence 2008; Mohammadi et al. 2010). Evaluation
of patients presenting with CTS manifestations has long
relied on their clinical symptoms as well as nerve con-
duction studies (NCS). Although standard symptoms
and positive provocative testing may enable identifying
acute cases, the subjectivity and sensitivity of these mea-
sures results in very poor reliability and diagnostic ac-
curacy (Kuhlman and Hennessey 1997; Salerno et al.
2000; Mondelli et al. 2001; El Miedany et al. 2008). Simi-
larly, though studies revealed sensitivity and specificity
data in favour of electrodiagnostic testing for the CTSs is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
inal work is properly credited.
Table 1 Correlation between Nerve conduction study
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Strickland and Gozani 2011), abnormal NCS results do
not necessarily equate to the correct diagnosis. Earlier re-
ports showed that NCS can be normal in early cases (El
Miedany et al. 2007). Furthermore, NCS were reported as
not sensitive to change or management, hence, a poor pre-
dictor of treatment outcomes (Evans et al. 2012).
Inspite of some limitations, ultrasonography (US) was
found to be a good tool not only for the CTS diagnosis,
but also for identifying the MN affection severity. In
comparison to NCS, US measurements had a sensitivity of
29.4% to 100% and specificity of 47% to 100% (Roll et al.
2011). On the other hand, MN hypervascularity showed
sensitivity and specificity of 50% (Wang et al. 2008) and
65% (Mallouhi et al. 2006) respectively. Better accuracy
was suggested by the combination of sonographic mea-
sures of the MN cross-sectional area (CSA), and hypervas-
cularity, which resulted in 90% concordance with the CTS
clinical presentation (Rahmani et al. 2011).
The search for markers identifying key targets for the
assessment of major outcomes in musculoskeletal dis-
eases has become one of the hot issues in rheumatology.
Possible markers should be objectively measured, indica-
tory of normal biology as well as the pathologic process,
indicator of response to therapy and prognosis. It should
also be a good indicator of modification of the pathological
process and help to identify (in early cases) the patients
who are going to respond quickly to therapy with the vi-
sion to tailor management to the patient status (Ferraccioli
et al. 2013). So far this target has not been achieved in
CTS. There have been many studies investigating US
changes following CTS management, however, few ones
were conducted to follow-up the changes (both NCS and
US) (Jeong et al. 2011). The novel concept of using US as-
sessment as a biomarker which can help in setting a “Treat
to Target” approach tailored for CTS patients, expands the
scope of using this tool in clinical practice. In this report
we present a large prospective US study of CTS patients.
The specific aim of the study was to assess the median
nerve both by Gray-scale US and neural vascular flow
(using Power Doppler (PD) before and after management.
Moreover, we investigated the feasibility of initial US pa-
rameters for setting up a treatment plan tailored to the pa-
tient’s needs and its ability to predict treatment outcomes.
Results
Results of patient baseline assessment
233 subjects (81% of those eligible for this study) com-
pleted the 6-months follow-up period. The mean age of
patients enrolled in the cohort was 53.7 + 3.71 years and
60% of the patients cohort (140/233 patients) were female.
The mean (SD) duration of clinical symptoms was 10 +
2.14 months (min 3 months and maximum 19 months)
months. There was no significant difference on comparingage and sex distribution in both CTS patient cohort and
the control group. Analysis of CTS duration of Illness pa-
tients stratified according to grade of CTS, revealed sig-
nificantly (p < .001) longer disease duration in the severe
subgroup (Median (IQR) was 15 (7.0) months), in com-
parison to 7 (6.0) months in the mild group and 8 (15.0)
months in the moderate subgroup.
Patient reported management outcomes (PROMs)
115/233 (49.4%) of the patient cohort were treated conser-
vatively (i.e. local injection, splints and exercise program,
whereas 118/233 (50.6%) were treated surgically. 81% (93/
115) of the patients, treated conservatively improved sig-
nificantly within 1–4 weeks and maintained their improve-
ment throughout the 6-months follow-up period. On the
other hand, 78% (92/118) of the patients treated surgically
took between 1–6 months to show similar improvement.
Overall satisfaction (>70% improvement on the global scale
was reported in 51/95 (53.7%) in the mild group versus 22/
76 (28.9%) in the moderate group and 11/60 (18.3%) in the
severe group at week-1 of follow up (p < 0.001). This im-
proved, at 6-month post management, to 87/118 (73.7%)
in the mild group, 53/76 (69.7%) in the moderate group
and 38/60 (63.3%) in the severe group. Symptom severity
scores improved from a pre-management average of 7.3
(SD 0.61) to 2.25 + 0.42 at 6-months, whereas functional
limitation scores improved from 3.8 + 0.37 to 1.2 + 0.26.
These differences between pre-management and follow-up
symptom severity and functional limitation scores were
highly statistically significant (P <0.001 for both).
Nerve conduction outcomes in response to management
Stratifying patients according to NCS outcomes revealed
severe MN compression (grade 5 and 6) in 60/233 (25.8%)
patients, moderate (grade 3 and 4) in 76/233 (32.6%), and
mild (grade 1 and 2) in 118/233 (50.6%). At baseline, there
was significant difference (p < 0.001) on comparing the dis-
tal sensory and motor latencies as well as the nerve con-
duction velocity in the 3 subgroups. Also there were
significant difference between the patients and the control
groups regarding these 3 variables. There was a significant
correlation between the main NCS outcomes and US mea-
sures (Table 1). On comparing pre- and post- management
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group (P < 0.01); whereas in the moderate group, though
the post-management NCS outcomes did not meet the
normal ranges, the improvement of the NCS figures
remained significant (P < 0.05). In contrast, the improve-
ment in the NCS outcomes did not achieve significant dif-
ference the severe group.
US outcomes
CSA, FR and PD score (>2) were the 3 main US out-
come measures which showed a significant relation both
at baseline and after treatment. There was significant in-
verse relation (r = −0.372, P < 0.03) between PD and dis-
ease duration. Enhanced vascularity (PD score >2) was
seen in 66/97 (68%) of the patients with disease dur-
ation < 6 months, whereas it was seen in 2/59 (3.4%) of
the patients with disease duration > 15- months. There was
also an inverse relationship between intra-neural vascular
flow and CTS severity based on NCS (r = −0.737) as well
as the presence of neurological manifestations (r = −0.642).
The MN sonographic changes in CTS can be divided into
3 phases: Phase 1 “Hypervascularity”: PD score of 2 or
greater. Initially, there was enhanced peri-neural vascular-
ity which extended later to intra-neural hypervascularity.
Hypervascularity was seen in 26/50 (52%) of the patients
who had mild (grade 1 and 2) CTS, whereas it was present
in 2/59 (3.4%) in severe CTS (grade 5 and 6) diagnosed ac-
cording to NCS. Phase 2 “Nerve edema”: swelling of the
MN at the CT entrance manifested by CSA > 10 mm2.
The median nerve CSA was significantly correlated with
duration of symptoms (r = 0.726. P < 0.01). In patient with
disease duration < 6 months, the mean CSA was 11.3 +
0.3 mm2, in patients with disease duration between 6–12
months mean CSA 14.04 + 0.4 mm2, whereas in patients
with disease duration > 12 months, CSA mean was 18.1 +
0.3 mm2. Phase 3 “nerve flattening”: Flattening was signifi-
cantly correlated (r = 0.516, p < 0.01) to severity of the MN
compression, identified by NCS. In mild MN compression,
the mean FR was 2.5, and in moderate nerve compression
the ratio was 2.8, whereas in severe compression it was
2.91. Table 2 shows the mean of the 3 US outcome mea-
sures in the CTS patients cohort stratified according to the
severity of their NCS before and after treatment.
US outcomes in response to management
PD was the first US outcome measure to show signifi-
cant change in response to management as early as 1-week.
This improvement remained till 1-month post-treatment,
the process then slowed down before platauing. Table 3
shows that the CSA and flattening ratio improved
significantly (back to normal range in patients with
mild or mild-moderate nerve compression, whereas
they remained unchanged in the severely compressed
cases. In contrast with NCS which did not show anysignificant correlation with the treatment response at
6-months, there was significant correlation (p < 0.01)
between baseline US variables, namely CSA, Flattening
ratio and PD, and the percentage of improvement at 1st
week, 1st month and 6-months post-treatment.
Multivariate model
In multivariate regression analyses involving the entire
cohort, greater pre-management CSA (>14.0 mm2) and
Flattening ratio (>2.8) were the most important predic-
tors of poorer outcome and presence of symptoms at 6-
months follow-up. Table 4 displays predictors of percent
improvement at 6 months follow up. Baseline CSA
(<14.0 mm2) and PD score (>2) at baseline were associ-
ated with better response at 6 months. Figure 1 is a scat-
terplot displaying actual percent improvement at
6 months follow-up. Figure 2 is an ROC assessing the
potential use of PD as a predictor of good outcome
(>70% improvement of the patient global score). Inde-
pendent of the disease duration, AUC was 0.755 with
sensitivity of 92.8% and specificity of 51.4% and positive
likelihood ratio of 1.91, whereas in the patient cohort
with disease duration < 6 months, AUC was 0.844 with
sensitivity of 89.3% and specificity 79.5% and positive
likelihood ratio of 4.353.
Reproducibility of ultrasound findings
The ICC of CSA (0.90; 95% CI 0.79 to 0.95) and flatten-
ing ratio (0.85; 95% CI 0.8 to 0.9), were high. The linear
weighted kappa coefficient for power Doppler assess-
ments was 0.78 (95% CI 0.76 to 0.81). The ICC for intra-
observer variability was 0.85 (95% CI 0.84 to 0.91).
Discussion
This study was carried out to assess the possibility of
using musculoskeletal US assessment of the median
nerve as a biomarker and whether it can be of help to
set a “Treat to Target” management plan tailored the pa-
tient’s status. This work supports the concept of US be-
ing a rapid, safe, and inexpensive technique which can
be useful to assess CTS patients both at baseline as well
as to assess their response to treatment. In comparison
to the control group, the 3 US outcome measures, PD,
CSA and nerve flattening ratio have shown high diag-
nostic accuracy and reliability which make them suitable
for the diagnosis of CTS, but also as a staging tool and
predictor of treatment outcome. There was an inverse
relation between the median nerve neural vasculature
(PD score >2) and disease duration, presence of neuro-
logical deficit as well as CTS severity (based on nerve
conduction results). The 3 US outcome measures also
correlated significantly with the nerve conduction study
measures (namely, distal sensory latency, distal motor
latency and nerve conduction velocity). Whilst, PD
Table 2 Mean and standard deviation of the 3 US outcome measures in the CTS patients cohort stratified according to
the severity of their NCS before and after treatment









Cross Sectional Area (CSA) Mild 11.34 (0.16) 10.92 (0.2) 9.81 (0.15) 9.78 (0.3) <0.001*
Moderate 14.4 (0.5) 15.4 (0.4) 11.1 (0.3) 11.09 (0.4) <0.001*
Severe 18.91 (0.7) 18.87 (0.6) 17.43 (0.7) 16.41 (0.5) <0.001*
Flattening Ratio Mild 2.52 (0.1) 2.33 (0.3) 2.2 (0.4) 2.02 (0.3) <0.001*
Moderate 2.84 (0.02) 2.6 (0.06) 2.47 (0.04) 2.42 (0.03) <0.001*
Severe 2.9 (0.2) 2.89 (0.4) 2.88 (0.3) 2.78 (0.2) <0.001*
Power Doppler Mild 1.28 (0.6) 0.2 (0.4) 0.04 (0.2) 0.09 (0.3) <0.001*
Moderate 2.1 (0.5) 1.08 (0.6) 0.49 (0.5) 0.05 (0.2) <0.001*
Severe 0.40 (0.5) 0.4 (0.5) 0.33 (0.5) 0.30 (0.46) <0.001*
*: P< 0.01.
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dictors of good outcome in response to management,
the risk of a poor outcome was significantly higher in the
patients with high median nerve flattening ratio at the car-
pal tunnel inlet, cross sectional area >14 mm2 and low PD
signal (score <2).
The significant inverse relation between PD signal and
disease duration of the disease and the presence of
neurological deficits, reflect the state of vasculature sta-
sis early during the disease process. The increased ven-
ous vasculature starts at the peri-neural sheath first then
extends to involve also the intra-neurium and conse-
quently lead to increase in the cross sectional area as a
result of the nerve edema. These findings are in agree-
ment with earlier published data (Lundborg et al. 1983;
Mackinnon et al. 1984; Lundborg and Dahlin 1996) sug-
gesting that the persistent edema and increased intersti-
tial pressure eventually lead to increase axonal transport
and intra-neural blood flow followed by fibroblastic ac-
tivity and scar formation in and about the nerve. This
would explain the flattening state of the median nerve
reported in this study in the more severe cases and the
patients with long disease duration.
Whilst the use of US to monitor response to therapy
focussed mainly on surgical decompression, the inter-
pretation of the reported US outcome measures haveTable 3 Correlation between “Baseline US findings” and
“% improvement of the US parameters” measured at 1st
week, 1st month and 6th month
US measure 1st wk 1st mth 6th mth
Cross Sectional Area −0.649* −0.195* −0.253*
Flattening Ratio −0.635* −0.144* −0.233*
Flexor Retinaculum −0.062 −0.068 −0.015
Power Doppler (PD) Score 0.632* 0.499* 0.264*
*: P< 0.01.been contradictory. In most of the earlier published re-
search (Lee et al. 2005; Hammer et al. 2006; Abicalaf
et al. 2007; Colak et al. 2007; Smidt and Visser 2008), a
significant decrease was recorded in the cross-sectional
area of the median nerve at the tunnel inlet ranging be-
tween 1 and 3 mm2. In the study carried out by Mon-
delli et al. (2008b), a correlation was reported between
the degree of reduction of the cross-sectional area after
surgery and both improvement of symptoms as well as
results of nerve conduction studies. On the other hand,
in the study carried out by Naranjo et al. (2010), no as-
sociation between clinical improvement and the reduc-
tion of the median nerve cross-sectional area after
surgery was found. Stratifying the patients based on the
severity of the median nerve compression, carried out in
this work, has helped to clarify this contradiction. Earlier
in the disease process and in patients with mild or mild-
moderate median nerve compression, there was signifi-
cant reduction of the median nerve cross sectional area
as well as the PD score. This improvement in the US
outcome measures was significantly associated with the
improvement of the patients’ symptoms. However, later
in the disease course, and in severe cases, where cross
sectional area exceeded 14 mm2 and the nerve got sig-
nificantly flattened, whilst there was some improvement
in the cross sectional area, this was not associated with
improvement of the nerve morphology or the patients’Table 4 Multivariate linear regression analysis displaying
predictors of percent improvement at 6 months follow up
Variables in the equation Unstandardized B (SE) P value
Constant 39.004 (6.2) <0.001*
Baseline Cross Sectional Area (CSA) −6.67 (2.06) 0.001*
Baseline PD (score >2) 0.699 (0.03) <0.001*
R2 0.717
*: P< 0.01.
Figure 1 Scatterplot displaying Actual Percent Improvement at 6 months FUP and Unstandardized Predicted Values of the Model.
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early intervention for CTS patients before significant
nerve damage occurs.
The published literature on predictors of outcomes
of surgery has some methodological limitations. Most
of the research studies implemented retrospective
paradigms, impeding expressive examination of pre-
operative important aspects such as the severity of the
patient-reported symptoms as well as functional disabil-
ity. On the other hand, few studies implemented stan-
dardized outcome measures which matter most to
patients such as symptoms relief, improvement of the
functional disability, as well as satisfaction (Levine et al.
1993; Bessette et al. 1997; El Miedany et al. 2014). In
general, a narrow array of potential predictors, focused
mainly on the prognostic significance of physiologic im-
paired parameters such as aberrations on neurophysio-
logical assessment and physical examination, have been
traditionally considered by most of the research studies.
This work was set up based on the analysis of the base-
line parameters in association with the clinical as well as
patient-reported management outcomes. This enabled
overcoming several of the aforementioned limitations. A
multidimensional model of predictors was implemented
including patient-reported management outcomes, se-
verity of symptoms, functional disability as well as pa-
tients’ satisfaction. Results of this work showed that
the patient-reported outcome measures, which represent
the key indicators of successful management approach
from the patient’s point of view Katz et al. 1994; Bessette
et al. 1997), were sensitive to change and correlatedsignificantly to changes in the US outcome measures
starting from the first week after treatment. This con-
curs with the earlier findings reported by Katz et al.
(2001), that patient reported outcome measures were
not only a valid management outcome measure, but
also a robust prognosticator of less favourable manage-
ment outcome.
An accurate assessment of predictors of outcomes for
carpal tunnel syndrome management would enable the
treating physicians as well as patients to make more in-
formed decisions about treatment approach whether
conservative or surgical, and to develop more precise
anticipation of outcomes. Several earlier studies have
explored the factors influencing the treatment outcomes
of carpal tunnel syndrome, in particular surgical decom-
pression. Poor management outcomes have been associ-
ated with pre-operative neurological deficit such as
muscle weakness or atrophy (Muhlau et al. 1984), worker’s
reimbursement (Higgs et al. 1995), exposure to vibration
(Hagberg et al. 1991), repetitive or heavy manual work (Yu
et al. 1992), predisposing medical conditions (Kulick et al.
1986) including thyroid disease and diabetes mellitus (De
Stefano et al. 1997), improper diagnosis (Eason et al.
1985), and incomplete sectioning of the flexor retinaculum
(Eason et al. 1985). Symptoms duration has been a matter
of controversy, as in some studies symptoms duration
were not associated with the management outcomes
(Al-Qattan et al. 1994), whereas in others, worse outcomes
were reported in patients with longer symptoms duration
(De Stefano et al. 1997). Furthermore, the severity of the
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Figure 2 ROC of using Power Doppler (PD) as a predictor of good outcome at 6-months of follow up in patients with disease duration
less than 6 months (a) and in the assessed patients independent of their disease duration (b).
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et al. 1994). In contrast with US, nerve conduction studies
identify only permanent nerve damage, but not intermit-
tent nerve disturbance particularly in early CTS cases. Re-
sults of this work revealed that US helps in the early
diagnosis of the condition, identifying the underlyingpathological cause, the progress of the condition and its
severity as well as response to management, which would
make it fit with the definition a biomarker. These findings
have important implications for clinical practice and fu-
ture research. Clinicians should incorporate these results
in their discussions with patients regarding the likely
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understand that having high PD score and mild to moder-
ate increase in the CSA (<14 mm2) all signify a more
favourable outcome to conservative management ap-
proach. This does not imply that patients with these risk
factors should be denied surgery; rather, the patient and
clinician should acknowledge that for complex reasons,
outcomes are typically better in the presence of these fac-
tors. On the other hand, surgical decompression should
be offered to the patients with significant flattening of the
median nerve (>2.8) as well as cross sectional area
(>14 mm2).
The methodological strengths of this study include
the high rate of participation, acceptable rate of subject
retention at follow-up, use of reliable and valid mea-
sures including patient reported outcome measures as
well as nerve conduction testing, and the availability of
potential predictors across numerous domains. Limita-
tions that should be acknowledged include a relatively
constrained set of potential workplace psychosocial pre-
dictors, perceived job strain, as well as availability of
support at work.
Conclusion
In addition to the diagnostic value of ultrasonography in
CTS, US is a tool fit to be a radiologic biomarker for
carpal tunnel syndrome. The detection of increased
neural vasculature of the median nerve is an indicator of
early median nerve affection and has a good prognostic
value and is in favour of a conservative management ap-
proach, whereas flattened median nerve with signifi-
cantly increase cross sectional area, warrant surgical
decompression as a treatment option.
Methods
Study
Prospective case–control study which included consecu-
tive patients attending the outpatient clinic and diag-
nosed to have CTS after clinical and neurophysiological
assessment. Local ethical and methodological protocols’
approval for this study conduction were obtained. All
the subjects who shared in the study signed an informed
consent in keeping with the Declaration of Helsinki.
Patients
Patients presenting with one or more of the following
symptoms in at least one wrist were included: (1) pares-
thesias, pain and/or sensory deficits in the hand in a me-
dian nerve distribution; (2) nocturnal/ early morning
worsening of paresthesias with disturbed sleep; (3) par-
esthesias relieved by hand movement or shaking; (4)
pain and/or paresthesias in a median nerve distribution
provoked by repetitive exercises; (5) weakness of fingers
supplied by the median nerve.Patients with previously diagnosed CTS, conditions
resulting in an increased risk of (associated) CTS such
as previous surgery at wrist, recent wrist fracture or
traumatic nerve injury, known inflammatory rheumatic
disease, metabolic disorders or pregnancy, patients with
known polyneuropathy or contraindications to electro-
physiological testing were excluded.
Clinical assessment
Clinical examination consisted of an evaluation of mus-
cular strength and trophic changes, sensory function and
clinical provocation tests including Phalen’s, reverse
Phalen’s and carpal tunnel compression test.
Neurophysiological assessment
Nerve conduction studies (NCS) were performed at the
symptomatic side(s) according to a routine protocol. Skin
temperature over the dorsum of the hand was kept at 34°C.
The sensory median nerve conduction velocity (normal
values 50 m/s), distal sensory latency (baseline to peak
amplitude from the second finger, with retrograde
stimulation being conducted at the wrist (14 cm prox-
imal area from the recording site) and the palm (7 cm
proximal area from the recording site), distal motor la-
tency (baseline to initial latency from the abductor pol-
licis brevis muscle center with stimulation performed at
the wrist, 7 cm from the recording site) and median
motor compound muscle action potential (5 mV) were
determined (El Miedany et al. 2004).
The patients with abnormal NCS were classified ac-
cording to electrodiagnostic grading (Bland 2000) into:
Grade 0: Normal standard and comparative tests.
Grade 1: Very mild CTS: Normal standard tests,
abnormal comparative tests or reduced nerve conduction
velocity of the median nerve across the carpal tunnel.
Grade 2: Mild CTS: Abnormal sensory with a normal
motor response that is, prolonged antidromic distal
sensory latency (DSL) >3.6 ms to the second digit.
Grade 3: Moderate CTS: Abnormal median sensory and
motor response that is, prolonged distal motor latency to
abductor pollicis brevis (APB) is >4.2 ms but <6.5 ms,
and prolonged antidromic distal sensory latency with
decreased amplitude sensory nerve action potential.
Grade 4: Severe CTS: Absence of sensory response,
abnormal distal motor latency to APB but still <6.5 ms
with decreased amplitude of compound muscle action
potential and abnormal EMG activity in abductor
policis brevis muscle.
Grade 5: Very severe CTS: Terminal latency to
APB >6.5 ms.
Grade 6: Extremely severe CTS: Absence of median
motor and sensory responses (surface motor potential
from APB <0.2 mV amplitude).
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toms, clinical evaluation and NCS results.
US assessment
Ultrasonography studies were performed by two sono-
graphers experienced in musculoskeletal sonography
using a Mylab 25, Esaote, Italy US machine, with a mul-
tifrequence linear transducer 14–18 MHz. Both sonogra-
phers were unaware of clinical and NCS results. Patients
were examined in the sitting position with hands resting
in a horizontal supine position on the examination table
with fingers semi-extended (Mondelli et al. 2008a).
A perpendicular angle of the probe was maintained
during analysis to prevent anisotropy and median nerve
deformation. imaging parameters were adjusted to maxi-
mise the contrast between examined structures. Power
Doppler settings were standardised accordingly: fre-
quency 11.9 MHz, pulse repetition frequency 600 Hz
(lowest possible avoiding motion artefacts most of the
time) and medium persistence.
The power Doppler gain was optimised by increasing
gain until noise appeared and then reduced just enough
to suppress the noise (Torp-Pedersen and Terslev 2008).
The transducer was applied on the wrist with the min-
imal possible pressure to avoid any impact on the intra-
neural vessels.
The Cross-sectional area (CSA) of the median nerve
was measured by continuous tracing a continuous line
at the inner hyper-echoic rim of the median nerve at the
carpal tunnel inlet (at the level of the pisiform and
scaphoid bones) (Ziswiler et al. 2005; Klauser et al.
2009). Images were magnified in order to reduce meas-
urement error. The CSA of the median nerve measured
was recorded. Flattening ratio defined as the ratio of the
major axis of the median nerve to its minor axis was
calculated.
Power Doppler signals were graded from 0 to 3, in
which 0 represented no power Doppler signal, 1 = one
single vessel within median nerve, 2 = two or three single
or two confluent vessels and 3 =more than three single
or more than two confluent vessels.
Response to management
In addition to baseline assessment, every patient was
assessed 1-week, 1-month, and 6-months after treatment.
At every visit, every patient completed a questionnaire to
record the change of their symptoms in response to treat-
ment using a 0–10 VAS scale (El Miedany et al. 2006a)
as well as a functional status assessment questionnaire
(El Miedany et al. 2006b). US measures of CSA and flat-
tening ratio as well as PD enhanced vascularity were re-
corded at 1-week, 1-month and 6-months visits. Nerve
conduction studies were repeated at 6-months after treat-
ment. All the patients who had neurological deficits(motor weakness, muscle wasting or sensory loss) were of-
fered open surgical decompression of the carpal tunnel.
The remaining patients were given the choice of having a
conservative management approach including local steroid
injection, splinting and exercise programs or surgical de-
compression of the carpal tunnel.
Reproducibility of ultrasound findings
Inter-observer variability of B-mode and power Doppler
findings was determined by intraclass correlation coeffi-
cient (ICC) and linear weighted κ coefficient, respectively,
based on data from 34 patients’ wrists analysed by two ul-
trasonographers at one visit. Intra-observer variability was
investigated by ICC using data from 30 patients.
Control group
112 healthy subjects of matching sex and age were
assessed as a control group. In addition to neurological
examination, every subject had nerve conduction studies
as well as Gray-scale and PD ultrasonography of their
wrists and median nerve.
Statistical analysis
Data collected were revised and introduced to a PC for
statistical analysis. Quantitative data are presented as
means and standard deviation while categorical data as
frequency and percentage distribution. Sample size and
distribution permitted the use of parametric tests as
student-t test for independent 2 groups’ comparison in
case of interval data or ANOVA if more than 2 groups
are included. Post-hoc Tukey test is used to test individ-
ual groups differences. Pearson chi-square test was used
to test association between 2 categorical variables, with
Yates correction in case of 2 × 2 tables and Fisher Exact
if less than 5 observations are encountered in one of the
cells of the table. P value is always set at 0.05. Pearson
correlation coefficient is used to test correlation between
parametric quantitative variables while Spearman's is re-
placed if non parametric (scores). Multiple linear regres-
sion analysis was conducted to assess for independent
biomarker(s) of prognosis (improvement at 6-months
follow up). Different models were compared to achieve
the best likelihood ratio. R2 was calculated as a measure
of predictability of the model to the response. Scatter-
plot displays the correlation of the percent of improve-
ment at 6 months and the unstandardized percent
predicted by the model. All statistical manipulation and
analyses were performed using the 15th version of SPSS.
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